By: Benzinga
UPDATE: JP Morgan Lowers PT on Edwards Lifesciences on Sapien US Launch
JP Morgan analyst Michael Weinstein published a report on Edwards Lifesciences (NYSE: EW ) that maintained its Neutral rating and lowered the price target from $88 to $82. JP Morgan reported that, “We view TAVR as one of the most exciting opportunities in MedTech over the next decade, with WW
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here